Colossal Biosciences Raises Funding at $20 Billion to $30 Billion Valuation
Colossal Biosciences is in talks to raise new funding at a valuation of $20 billion to $30 billion, according to reports.
The deal values the de-extinction startup at up to three times what it reached in early 2025. The company is developing projects aimed at reviving species including the woolly mammoth and the dire wolf.
From the sources (4 posts)
@polymarketmoneyJUST IN: Colossal Biosciences is reportedly raising new funding at a $30,000,000,000.00 valuation as it works to revive species including the dire wolf and woolly mammoth.
@wallstengineColossal Biosciences, the de-extinction startup trying to revive species like the dire wolf and woolly mammoth, is reportedly in talks to raise new funding at a $20 billion to $30 billion valuation. Roughly 2x to 3x jump in valuation fr
@techcrunchColossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
@realjimchanosWooly Mammoth startup Colossal seeking at least $20B valuation (Up 100% from last year’s valuation round). I think I’ve seen an entire movie series about this concept.